user avatar
Christopher O'Connor
@coconnormd
President, INOVA Heart and Vascular Institute || Professor,Duke University || Founding Editor,JACC-HF ll Past President -HFSA,Father 4 children.comments my own
Washington DC
Joined March 2015
Posts
  • user avatar
    Breaking news Javed Butler MD - accepted the position: Senior VP of Baylor Scott&White Health System and President of BSW Research Institute..a great promotion for Javed even better for patients , clinical research ,family;and Milton finally has a boss!😊 google.com/search?q=javed…
  • user avatar
    An opportunity to spend a moment with my daughter, Erin, before her wedding Saturday 😊
  • user avatar
    I lost my mom tonight.Thank you God for sudden death.I recognize the pain of my friends.My mom left WWII: became governess for Dr.Sarnoff,married,3 kids,told me become cardiologist,lost husband:55,built life around family.My North Star,Thank you Mom🙏
  • user avatar
    Friends, with my last Year-in-Review Top 10 Picks 2021. It's been a privilege to serve as JACC-HF EIC. I especially want to thank my AE's, reviewers, authors, and HF Community, who have supported this innovative journal effort the past 10 years dedicated to the patients we serve.
  • user avatar
    In the complex world we live of continued human suffering, war, climate, politics,we take pause to welcome grandson,MasonChristopher, son of Erin and Kevin,to a world of challenges/opportunities to make better for all.🙏⁦@DrCaliff_FDA⁩ ⁦@HeartBobH⁩ ⁦@texhern
  • user avatar
    Dr Braunwald introduces new sub specialty diabetocardiology at Inova Heart Failure symposium
  • user avatar
    The Duke community lost one of its greatest leaders ,Dr Joseph Greenfield,Chairman Medicine Emeritus,James B.Duke Professor. Renowned coronary blood flow physiologist,who stimulated landmark AMI research.Mentor to 1000 residents,faculty, and me . A dear friend.RIP
  • user avatar
    Terrific coordinating center leadership publishing11 simultaneous papers from DELIVER, majority lead by young investigators. The early full disclosure of the drug overall and in subgroups should lead to better implementation. ⁦@mvaduganathan⁩ ⁦⁦⁦@scottdsolomon
  • user avatar
    Top HF stories 2018: 1. Transcath MV repair:+. 2. HRRP increase mortality 3.SGLT2 inhibitors reduce HF 4.ARNI in ADHF:+ 5.Riva in HF neutral 6. ablation afib+HF:+ 7.HM3 2yr outcomes:+ 8. CCM fast track FDA panel:+ 9. Cell therapy trial stopped10.Intrarial shunt:HFpEF:+
  • user avatar
    Happy NY! As I reflect on this complex year, I say thank you HF community for your sacrifice, contributions to patients and knowledge in 2021. Let’s look forward to a better 2022. What great work you have done in the midst of a pandemic .Thank you !
  • user avatar
    Should all doctors ( beginning in medical school ) be trained in palliative care? heartfailure.onlinejacc.org/content/early/…
  • user avatar
    Mentor and Mentee: Eric Peterson, Dudley visiting Professor at Inova, runs into his former fellow, Lauren Cooper, right out of cath lab; our legacy is not our papers, it’s our colleagues
  • user avatar
    Go Red for Women from Inova Schar Heart and Vascular ⁦@HeartBobH
  • user avatar
    Now Tommy Christopher / the HF alphabet is: ARNI,BB,MRA,SGLT2I